Shaolin Capital Management’s Aimei Health Technology Co Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.2K Buy
100,831
+831
+0.8% +$232 ﹤0.01% 537
2026
Q1
$30.8K Sell
100,000
-50,000
-33% -$18.6K ﹤0.01% 461
2025
Q4
$56.1K Sell
150,000
-49,220
-25% -$18.6K ﹤0.01% 355
2025
Q3
$63.8K Hold
199,220
﹤0.01% 281
2025
Q2
$47.8K Sell
199,220
-600
-0.3% -$153 ﹤0.01% 233
2025
Q1
$71.9K Sell
199,820
-65,180
-25% -$16.7K ﹤0.01% 125
2024
Q4
$47.7K Buy
265,000
+11,900
+5% +$2.59K ﹤0.01% 138
2024
Q3
$58.2K Buy
253,100
+53,100
+27% +$13.1K ﹤0.01% 121
2024
Q2
$42K Sell
200,000
-50,000
-20% -$11.2K ﹤0.01% 179
2024
Q1
$50K Buy
+250,000
New +$49.5K ﹤0.01% 170

Other funds holding AFJKR

Shaolin Capital Management's AFJKR Position: Q2 2026 in Review

Shaolin Capital Management increased its Aimei Health Technology Co Right (AFJKR) stake by 0.83% in Q2 2026, buying an estimated $232 and bringing the position to 100,831 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Shaolin Capital Management first reported a position in AFJKR in Q1 2024 and has held it in 10 quarters since. The position peaked at $71.9K in Q1 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q2 2026.

  • Shaolin Capital Management held 100,831 shares of Aimei Health Technology Co Right worth $23.2K as of Q2 2026.
  • Shaolin Capital Management bought 831 Aimei Health Technology Co Right shares in Q2 2026, an estimated $232.
  • Aimei Health Technology Co Right made up ﹤0.01% of Shaolin Capital Management's portfolio in Q2 2026, its #537 holding.
  • Shaolin Capital Management first reported a position in Aimei Health Technology Co Right in Q1 2024 and has held it in 10 quarters since.
  • Shaolin Capital Management's Aimei Health Technology Co Right position peaked at $71.9K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Co Right as of Q2 2026.

Based on Shaolin Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.